MENU
IFRX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
InflaRx (IFRX) Ownership - Who owns InflaRx?
InflaRx NV is a clinical-stage biopharmaceutical company focused on applying proprietary anti-C5a/C5aR technology to discover and develop first-in-class, potent, and specific inhibitors of the complement activation factor known as C5a and its receptor known as C5aR... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
Winzerlaer Strasse 2
Phone
+49 3641508180
Employees
66
Web
https://www.inflarx.de
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
59.62M
P/E Ratio
N/A
Total Cash
65.86M
Projected Growth
N/A
Total Debt
702.63K
Revenue
129.75K
Risk (Beta)
0.39
Dividend Yield
N/A
Total Cash/Share
0.97
Total Debt/Equity
N/A
Revenue/Share
0.00 USD as % of share price
Fundamentals
IFRX
Capitalization
59.6M
P/E Ratio
N/A
Risk (Beta)
0.39
Dividend Yield
N/A
Total Cash
65.9M
Total Cash/Share
0.97
Total Debt
703K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.00%
Revenue
130K
ROE
N/A
Book Value
70.5M
P/B Ratio
0.72
Cash Flow
N/A
Earnings
-0.74
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
8.13M
Current Ratio
5.28
Current Revenue Per Employee
1876.05
Dividends Per Share - Security
N/A
EBITDA
-44.22M
Float
N/A
Float - Current
N/A
Gross Income Margin
158.60
Revenue To Assets
-46.08
Shares Held By Institutions
17.2M
Shares Outstanding - Current
67.7M
Total Liabilities
16.5M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-65.182
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of biopharmaceutical products
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
Winzerlaer Strasse 2
Phone
+49 3641508180
Employees
66
Web
https://www.inflarx.de